Desmopressin

Basic desmopressin information

• International nonproprietary name (INN): desmopressin (as desmopressin acetate)
• Brand names available in the United Kingdom: DDAVP, Desmotabs, Desmomelt; generic desmopressin
• ATC code: H01BA02
• Forms and dosages: tablets (0.1 mg, 0.2 mg); oral lyophilisates (melts); nasal spray (10 micrograms per dose); injection
• Manufacturers in the United Kingdom: Ferring Pharmaceuticals; generic manufacturers
• Registration status in the United Kingdom: licensed by the MHRA; prescription only
• OTC / Rx classification: Prescription-only medicine (POM)

Everyday use and best practices

When considering the timing for taking desmopressin, understanding your daily routine is crucial. Generally, it's recommended to take desmopressin either in the morning or evening, depending on the condition being treated. For managing diabetes insipidus, morning dosing is often suggested as it aligns well with daytime activities, ensuring optimal benefits throughout the day. Conversely, for those dealing with nocturnal enuresis (bedwetting), evening dosing is more widespread.

Factors that influence timing include:

• Daily schedule: Those with busy mornings may prefer evening doses.
• Impact on lifestyle: Taking it at a consistent time aids in establishing routine.

Choosing between morning and evening can have implications on effectiveness. Morning dosing can lead to better hydration and control during the day for diabetes patients, while evening dosing supports bladder control overnight for those experiencing bedwetting. Patients should discuss these options with healthcare providers to determine what's best for their unique situations.

Taking with or without meals

Desmopressin tablets can be taken regardless of meal timing, although food can reduce absorption, so it is helpful to take the dose consistently in relation to meals. Follow your prescriber’s advice.

Fluid intake needs particular care:

• For diabetes insipidus, drink enough to satisfy thirst, as advised by your doctor.
• For bedwetting (nocturnal enuresis) or nocturia, limit fluids in the evening and overnight, as drinking too much while taking desmopressin can cause dangerously low blood sodium (hyponatraemia).

Consult a healthcare professional for personalised advice on timing doses in relation to meals.

Safety priorities

Who should avoid it

Desmopressin should not be used by people with:

• Known hyponatraemia (low blood sodium) or a history of it
• Habitual or psychogenic polydipsia (excessive drinking)
• Heart failure or other conditions treated with diuretics
• Moderate to severe renal impairment
• Syndrome of inappropriate antidiuretic hormone secretion (SIADH)
• Known hypersensitivity to desmopressin or its ingredients

The elderly, particularly those with diminished renal function, are more susceptible to hyponatraemia. Report headache, nausea, vomiting or confusion to a doctor promptly.

Activities to limit (driving, work safety)

Headache and dizziness are among the side effects that can impair alertness and coordination. Patients are encouraged to monitor how they feel after taking desmopressin. It is wise to:

• Evaluate personal tolerance before driving
• Avoid heavy machinery if experiencing any side effects
• Keep a close dialogue with healthcare providers about any changes in side effects

Dosage and adjustments

General regimen

The dose of desmopressin depends on the condition being treated and is adjusted for each patient by the prescriber.

• Diabetes insipidus (tablets): usually started at 0.1 mg three times daily, adjusted to response, with a typical total daily dose of 0.2 to 1.2 mg.
• Diabetes insipidus (nasal spray): 10 to 40 micrograms daily, in one to three doses.
• Nocturnal enuresis in children over 5 years: usually 0.2 mg at bedtime, which may be increased by the prescriber, with fluid restriction in the evening.

Regular monitoring is important, especially for those new to desmopressin therapy, as adverse effects such as headache, abdominal pain and low blood sodium need supervision by healthcare professionals.

Special cases (elderly, comorbidities)

Elderly patients often have decreased renal function and a higher risk of hyponatraemia, so treatment should start cautiously with careful monitoring of blood sodium and renal function.

• Initial doses of desmopressin should be conservative.
• Regular blood tests (sodium and kidney function) should be carried out to ensure safety.
• Moderate to severe renal impairment is a contraindication.

Patients with other comorbid conditions, such as heart failure or those taking diuretics, may not be able to use desmopressin safely, so close monitoring and specialist advice are vital.

Delivery options for desmopressin